Also trades as: ATX.AX (ASX) · $vol 0M
INNMF OTC
Amplia Therapeutics Limited
1W: -13.0%
1M: -11.1%
3M: -30.4%
YTD: -25.8%
1Y: -20.0%
3Y: +61.6%
5Y: -48.7%
$0.08
-0.01 (-5.88%)
Weekly Expected Move ±12.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$9M
-27.1% ▼
Capital Expenditures
$33K
-1510.4% ▼
5Y CAGR: +44.2%
Free Cash Flow
-$9M
-27.5% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$18M
+141.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4M | -$6M | -$5M | $0 | -$8M |
| Depreciation & Amort. | $3K | $73K | $86K | $0 | $92K |
| Stock-Based Comp. | $61K | $209K | $0 | $0 | $0 |
| Change in Working Capital | -$822K | $670K | -$2M | -$668K | -$1M |
| Other Non-Cash Items | $889K | -$313K | $1M | -$6M | $268K |
| Operating Cash Flow | -$4M | -$5M | -$5M | -$7M | -$9M |
| — Investing Activities — | |||||
| Capital Expenditures | -$14K | -$18K | -$2K | -$2K | -$33K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$12K | -$41K | $0 | $0 | -$63K |
| Investing Cash Flow | -$27K | -$58K | -$2K | -$2K | -$96K |
| — Financing Activities — | |||||
| Net Debt Issuance | $2M | -$65K | -$633K | -$2M | $0 |
| Stock Repurchased | -$1M | $0 | $0 | -$1M | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$41K | -$140K | -$81K | -$89K |
| Financing Cash Flow | $17M | -$84K | -$773K | $14M | $26M |
| Net Change in Cash | $13M | -$5M | -$6M | $7M | $18M |
| Cash End of Period | $15M | $9M | $3M | $11M | $28M |
| Free Cash Flow | -$4M | -$5M | -$5M | -$7M | -$9M |